Application 208837
- Type
- ANDA
- Sponsor
- DR REDDYS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 100MCG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208837-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2020-03-27 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2020-03-27 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2020-03-27 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208837-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | 2020-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2021-03-12 10:30 UTC | 2021-03 | A208837-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A208837-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A208837-001 | AP | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | American Health Packaging | 38af4e36-b26b-485d-a6f3-7fbcf6072a0f | 2025-06-16 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | f0680426-3581-400c-8ab5-5e6f18d0cabc | 2025-06-09 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b4654497-c986-4792-9b6b-0a791c7c205b | 2025-06-06 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 0e0ad9f1-1f52-48ce-a996-79ebe7ad53cd | 2025-06-06 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 247f4d1d-6e65-4f81-a377-4dd88ae16dbb | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70dddaf0-f495-495f-95de-36e9efa2e373 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 91afb351-f067-49a2-bdf0-336ea209718d | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 237cc591-c40b-416f-ac00-96cd61bc59dc | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | faaa1123-7515-46c2-abbb-b0615540c8cf | 2025-05-22 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7f8ec438-8ddf-45d2-be94-ac032e192229 | 2025-05-19 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fosun Pharma USA Inc. | 3361138a-6e6f-e8df-e063-6294a90af2de | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | ENDO USA, Inc. | 9d815416-11c9-470e-a82f-89b0bf232e12 | 2025-04-28 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | f5fc0f34-744c-4e03-ae9f-e017e4033139 | 2025-04-24 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM ANHYDROUS | Fresenius Kabi USA, LLC | ce990712-49c1-4f66-9ee4-c770e8ec394c | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 65b266af-72a5-4409-ab55-bd14341135aa | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 30ccec8b-3f95-61c7-e063-6394a90a05a0 | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Lupin Pharmaceuticals, Inc. | 18717e58-89fb-4e2f-93b6-d6ac3e988d37 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | f0a63075-631d-43bf-9d8e-df79faf0a278 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.